Teva is happy to announce the 2nd Nordic Migraine Symposium which will be held in Oslo, Norway.

The topics and speakers have been selected by a Steering Committee consisting of leading migraine experts from the Nordic countries.

Steering Committee

Messoud Ashina
Professor of Neurology at Rigshospitalet Glostrup, Denmark.

Mattias Linde
Professor of Neurology in the Department of Neuroscience, Norwegian University of Science and Technology, Director of Tjörn Headache Clinic, Sweden.

Mikko Kallela
Assistant Professor, Neurology specialist at Helsinki University Central Hospital and Helsinki Headache Center, Finland.

Anne Christine Poole
General practitioner and headache specialist at Oslo Headache Center AS, Norway.  


If you have any questions regarding the symposium, please contact your local Teva medical representative:
Denmark: Nadeem Mohammad / Nadeem.Mohammad@tevapharm.dk
Sweden: Fredrik Blomstrand / Fredrik.Blomstrand@teva.se
Norway: Nils Gamlem / Nils.Gamlem@tevaeu.com
Finland: Kari Alhainen / Kari.Alhainen@tevapharm.com 

We look forward to seeing you in Norway!

On behalf of the Steering Committee and Teva Neuroscience

About the Nordic Migraine Symposium

Teva is a global company working in generics and specialty medicine, with focus on innovation in respiratory, pain and CNS. Teva is committed to bringing medicine, education and innovative solutions to health care professionals and with the ultimate goal of improving patient lives.

Aligned with this commitment, Teva Nordics has since 2013 arranged an annual scientific symposium within multiple sclerosis intended to be complementary to other international congresses and with highest clinical and scientific relevance. These symposia continue within the field of migraine having top international migraine experts in the steering committee and as speakers. We strive to provide the speakers an opportunity to present their work/research in an environment facilitating interactions and discussions.

Registration will open later and you will be informed accordingly.


The Symposium and Covid-19

Teva keeps a close eye on the evolving situation regarding the Covid-19 outbreak. The Symposium will take place even if travel restrictions are still in place, on 27-28 November 2020, and will either be taking place in Oslo, or broadcast online in its entirety. Either way, you can block the dates in your calendar already.